Carregant...
Exposure‐response analysis for evaluation of semaglutide dose levels in type 2 diabetes
AIMS: To evaluate dose levels for semaglutide, a glucagon‐like peptide‐1 analogue approved for the treatment of type 2 diabetes, by examining the effects of demographic factors on efficacy and safety in an exposure‐response analysis. METHODS: We analysed data from 1552 adults from four randomized ph...
Guardat en:
| Publicat a: | Diabetes Obes Metab |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Publishing Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099226/ https://ncbi.nlm.nih.gov/pubmed/29748996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13358 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|